Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,610
Closed -$1.22M 1234
2022
Q2
$1.22M Buy
+17,610
New +$1.31M 0.09% 388
2021
Q3
Sell
-7,694
Closed -$513K 1039
2021
Q2
$513K Sell
7,694
-5,691
-43% -$380K 0.17% 184
2021
Q1
$996K Buy
+13,385
New +$1.02M 0.32% 109
2017
Q1
Sell
-95,902
Closed -$3.85M 330
2016
Q4
$3.85M Buy
95,902
+55,886
+140% +$2.16M 1.1% 3
2016
Q3
$1.55M Buy
40,016
+5,625
+16% +$212K 0.45% 56
2016
Q2
$1.19M Buy
34,391
+23,565
+218% +$816K 0.48% 54
2016
Q1
$373K Sell
10,826
-8,194
-43% -$286K 0.14% 242
2015
Q4
$736K Buy
19,020
+11,400
+150% +$444K 0.34% 109
2015
Q3
$298K Buy
+7,620
New +$302K 0.17% 220

Other funds holding HOLX

Algert Global's HOLX Position: Q3 2022 in Review

Algert Global sold out of Hologic (HOLX) in Q3 2022, closing a stake of 17,610 shares — an estimated $1.22M sold.

Algert Global first reported a position in HOLX in Q3 2015 and held it in 9 quarters. The position peaked at $3.85M in Q4 2016. 653 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Algert Global reported no remaining Hologic position as of Q3 2022 after selling out during the quarter.
  • Algert Global sold 17,610 Hologic shares in Q3 2022, an estimated $1.22M.
  • Algert Global first reported a position in Hologic in Q3 2015 and held it in 9 quarters.
  • Algert Global's Hologic position peaked at $3.85M in Q4 2016.
  • 653 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Algert Global's 13F filing for Q3 2022, filed 15 Nov 2022.